The Indian pediatric HIV epidemic: A systematic review

Current HIV Research

Volumn 6, Issue 5, 2008, Pages 419-432

  Singh, Harjot Kaur ^a   Gupta, Amita ^a   Siberry, George Kelly ^a   Gupte, Nikhil ^a   Sastry, Jayagowri ^a   Kinikar, Arti ^b   Shah, Ira ^c   Gangakhedkar, Raman Raghunathrao ^d   Bollinger, Robert Cyril ^a   Kulkarni, Vinay ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Sassoon Hospital   (India)

^c B J WADIA HOSPITAL FOR CHILDREN   (India)

^d NATIONAL AIDS RESEARCH INSTITUTE   (India)

^e Amrita Clinic   (India)

Author keywords

Child; HIV; India; Systematic review

Indexed keywords

AMYLASE; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS STAVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LIVER ENZYME; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ABDOMINAL PAIN; ANEMIA; ANGIONEUROTIC EDEMA; ANTIBODY DETECTION; BREAST FEEDING; CD4+ T LYMPHOCYTE; CHILDHOOD MORTALITY; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EARLY DIAGNOSIS; EMBASE; EPIDEMIC; FAILURE TO THRIVE; FATTY LIVER; GASTRITIS; GENOTYPE; HEPATITIS; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INDIA; INFECTION RISK; LIVER TOXICITY; MALNUTRITION; MEDLINE; MOLECULAR EPIDEMIOLOGY; MONOTHERAPY; NEWBORN SCREENING; OBSERVATIONAL STUDY; OPPORTUNISTIC INFECTION; PANCREATITIS; POPULATION RESEARCH; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SEX RATIO; SHORT COURSE THERAPY; SIDE EFFECT; SINGLE DRUG DOSE; SYMPTOM; SYSTEMATIC REVIEW; THALASSEMIA; TUBERCULOSIS; VERTICAL TRANSMISSION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGY, MOLECULAR; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; INFANT; INFANT, NEWBORN; MALE; SEX FACTORS;

EID: 53849130648     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016208785861203     Document Type: Review

References (100)

1. Khanna SA, Lanjewar DN, Samdani PG and Shinde AB. Perinatally acquired AIDS. Indian Pediatr 1993; 30: 508-10.
2. UNAIDS, NACO. Revised estimates show lower HIV prevalence in India, July 6, 2007. Available at: http://www.unaids.org/en/MediaCentre/ PressMaterials/FeatureStory/20070704_India_new_data.asp (Accessed March 22, 2008).
3. National AIDS Control Organization. Note on HIV Sentinel Surveillance and HIV Estimation, 01 Feb 08, 2008. Available at: http://hvww.nacoonline.org (Accessed June 14, 2008).
4. National AIDS Control Organization, Ministry of Women and Child Health, Government of India and UNICEF. Policy Framework for Children and AIDS: India [PDF], 2007.
5. National AIDS Control Organization. Facts and Figures: Monthly updates on AIDS (updated 3 1, August 2006). Available at: http://www.nacoonline.org/facts_reportaug.htm. (Accessed March 22, 2008).
6. National AIDS Control Organization, Indian Academy of Pediatrics, UNICEF, World Health Organization. Manual for Management of HIV/AIDS in Children [in India], 2005.
7. Newell ML, Coovadia H, Cortina-Boda M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364: 1236-43.
8. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Cote d'Ivoire. AIDS 2004; 18: 1905-13.
9. Reddi A, Leeper SC, Grobler AC, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr 2007; 7: 13.
10. UNICEF. Information by Country (India, South Africa, Nigeria): Statistics: Basic Indicators, Nutrition Indicators, Health Indicators. Available at: http://www.unicef.org/infobyeountry/index.html (Accessed June 5, 2008).
11. Kaul D and Patel JA. Clinical manifestations and management of pediatric HIV infection. Indian J Pediatr 2001; 68: 623-31.
12. Shah SR, Tullu MS and Kamat JR. Clinical profile of pediatric HIV infection from India. Arch Med Res 2005; 36: 24-31.
13. Gupta A, Nayak U, Ram M, et al. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005. Clin Infect Dis 2007; 45: 241-9.
14. Gupta A, Gupte N, Sastry J, et al. Mother-to-child transmission of HIV among women who chose not to exclusively breastfeed their infants in Pune, India. Indian J Med Res 2007; 126: 1314.
15. Lodha I, Upadhyay A, Kapoor V, Kabra SK. Clinical profile and natural history of children with HIV infection. Indian J Pediatr 2006; 73: 201-4.
16. Madhivanan P, Mothi SN, Kumarasamy N, et al. Clinical manifestations of HIV infected children. Indian J Pediatr 2003; 70: 615-20.
17. Chibber R, Khurranna A. Birth outcomes in perinatally HIV-infected adolescents and young adults in Manipur, India: a new frontier. Arch Gynecol Obstet 2005; 271: 127-31.
18. Chattopadhya D, Aggarwal R, Kumari SS, Verghese T, Sen S. Lack of evidence of HIV-2 infection among multitransfused thalassemic children in the city of New Delhi. J Trop Pediatr 1996; 42: 116-7.
19. Yadav S, Chattopadhya D, Prakash C, Kumari S, Vergheese T. Role of transfusion-mediated viral infections on the lymphocyte subset profile in multi-transfused children. J Trop Pediatr 1993; 39: 243-50.
20. Patil RS, Wadgaonkar P, Joshi SH, Merchant RH, Gupte SC. Viral infections in newborns through exchange transfusion. Indian J Pediatr 1998; 65: 723-8.
21. Pandhi D, Reddy BS, Chowdhary S, Khurana N. Cutaneous tuberculosis in Indian children: the importance of screening for involvement of internal organs. J Eur Acad Dermatol Venereol 2004; 180: 546-51.
22. Lodha R, Singhal T, Jain Y, Kabra SK, Seth P, Seth V. Pediatric HIV infection in a tertiary care center in North India: early impressions. Indian Pediatr 2000; 37: 982-6.
23. Biswas J, Kumar AA, George AE, et al. Ocular and systemic lesions in children with HIV. Indian J Pediatr 2000; 67: 721-4.
24. Cherian T, Verghese VP. Tuberculosis with human immunodeficiency virus infection. Indian J Pediatr 2000; 67: S47-52.
25. Chattopadhya D, Aggarwal R, Prakash C, Sen S, Kumari S. Sexually-transmitted disease (STD) markers in multitransfused children in relation to human immunodeficiency virus type-1 (HIV-1) infection: impact of STD markers in blood donors. J Trop Pediatr 1997; 43: 178-81.
26. Giri TK, Wali JP, Meena HS, Pande I, Uppal S, Kailash S. Sociodemographic characteristics of HIV infection in northern India. J Commun Dis 1995; 27: 1-9
27. Daga SR, Verma B, Gosavi DV. HIV infection in children: Indian experience. Indian Pediatr 1999; 36; 1250-3.
28. Dhurat R, Manglani, M, Sharma R, Shah NK. Clinical spectrum of HIV infection. Indian Pediatr 2000; 37: 831-6.
29. Merchant RH, Oswal JS, Bhagwat RV, Karkare J. Clinical profile of HIV infection. Indian Pediatr 2001; 38: 239-46.
30. Khan MA. Psycho-social aspects of HIV infection and AIDS in multiple transfused thalassemic children. Indian J Pediatr 1992; 59: 429-34.
31. Kumar A, Upadhyay S, Kumari G. Clinical Presentation, treatment outcome and survival among the HIV infected children with culture confirmed tuberculosis. Curr HIV Res 2007; 5: 499-504.
32. Sehgal R, Baveja UK, Chattopadhya D, Chandra J, Lal S. Pediatric HIV infection. Indian J Pediatr 2005; 72: 925-30.
33. Shah I, Prabhu SS, V S, Shashikiran HS. Cardiac dysfunction in HIV infected children: a pilot study. Indian Pediatr 2005; 42: 146-9.
34. Shah I. Age related clinical manifestations of HIV infection in Indian children. J Trop Pediatr 2005; 51: 300-3.
35. Shah I. Correlation of CD4 count, CD4% and HIV viral load with clinical manifestations of HIV in infected Indian children. Ann Trop Paediatr 2006; 26: 115-9.
36. Verma S, Bhatia R. Pediatric HIV infection/AIDS in Agra. Indian Pediatr 2005; 42: 953-4.
37. Angami K, Sudha Reddy VR, Singh KI, Singh NB, Singh PI. Prevalence of HIV infection and AIDS symptomatology in malnourished children - A hospital based study. J Commun Dis 2004; 36: 45-52.
38. Agrawal M, Koppikar GV, Ghildiyal R, Chavarkar M, Joshi SM, Lahiri KR. Seropositivity rate for HIV infection in hospitalized children on selective screening. Indian Pediatr 2001; 38: 267-71.
39. Kumar RM, Rizk DE, Khuranna AK. Unscreened transfusion related human immunodeficiency virus type-I infection amongst Indian thalassemic children. Am J Hematol 1996; 53: 51-2.
40. Lahiri S, Shahab T, Malik A, Alam S. HIV seropositivity in hospitalized children with high clinical likelihood of AIDS. Indian Pediatr 2002; 39: 372-5.
41. Karande S, Bhalke S, Kelkar A, Ahuja S, Kulkarni M, Mathur M. Utility of clinically-directed selective screening to diagnose HIV infection in hospitalized children in Bombay, India. J Trop Pediatr 2002; 48: 149-55.
42. Bavdekar SB, Agarwal R. Clinically directed selective screening for HIV infection in hospitalized children. Indian Pediatr 2005; 42: 1191-7.
43. Hussain T, Sinha S, Talan S, et al. Seroprevalence of HIV infection among paediatric tuberculosis patients in Agra, India: a hospital-based study. Tuberculosis (Edinb) 2007; 87: 7-11.
44. Merchant RH, Shroff RC. HIV seroprevalence in disseminated tuberculosis and chronic diarrhea. Indian Pediatr 1998; 35: 883-7.
45. Shah I, Katira B. Seroprevalence of HIV infection in hospitalized paediatric patients at a tertiary care centre in western India. HIV Med 2007; 8: 265-6.
46. Shahab T, Zoha MS, Malik MA, Malik A, Afzal K. Prevalence of human immunodeficiency virus infection in children with tuberculosis. Indian Pediatr 2004; 41: 595-9.
47. Parthasarathy P, Mittal SK, Sharma VK. Prevalence of pediatric HIV in New Delhi. Indian J Pediatr 2006; 73: 205-7.
48. Muralidhar S, Ray K, Bala M, Salhan R. Trend of paediatric HIV/AIDS cases in a tertiary care hospital in Delhi. J Paediatr Child Health 2006; 42: 660-1.
49. Havaldar PV, Patil M. HIV seroprevalence by ELISA in high risk Indian children and their presentation. J Trop Pediatr 2001; 47: 119-20.
50. Merchant RH, Damania K, Gilada IS, et al. Strategy for preventing vertical transmission of HIV: Bombay experience. Indian Pediatr 2001; 38: 132-8.
51. Jindal N, Aggarwal A. Perinatal transmission rate of HIV infection in Amritsar (Punjab). Indian J Med Microbiol 2006; 24: 146-7.
52. Shah I. Is elective caesarian section really essential for prevention of mother to child transmission of HIV in the era of antiretroviral therapy and abstinence of breast feeding? J Trop Pediatr 2006; 52: 163-5.
53. John TJ. Frequency of mother-to-infant transmission of human immunodeficiency virus. Indian Pediatr 2000; 37: 1027-8.
54. Kumar RM, Uduman SA, Khurrana AK. Impact of pregnancy on maternal AIDS. J Reprod Med 1997; 42: 429-34.
55. Kumar RM, Uduman SA, Khurranna AK. Impact of maternal HIV-1 infection on perinatal outcome. Int J Gynaecol Obstet 1995; 49: 137-43.
56. Kumar RM, Uduman SA, Khurranna AK. A prospective study of mother-to-infant HIV transmission in tribal women from India. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 9: 238-42.
57. Kumar RM, Khuranna A. Pregnancy outcome in women with beta-thalassemia major and HIV infection. Eur J Obstet Gynecol Reprod Biol 1998; 77: 163-9.
58. Shah I. Adverse effects of antiretroviral therapy in HIV-1 infected children. J Trop Pediatr 2006; 52: 244-8.
59. Lodha R, Upadhyay A, Kabra SK. Antiretroviral Therapy in HIV-1 Infected Children. Indian Pediatr 2005; 42: 789-96.
60. Natu SA, Daga SR. Antiretroviral therapy in children: Indian experience. Indian Pediatr 2007; 44: 339-43.
61. Pensi T. Fixed dose combination of lamivudine, stavudine and nevirapine in the treatment of pediatric HIV infection: a preliminary report. Indian Pediatr 2007; 44: 519-21.
62. Phadke MA, Gadgil B, Bharucha KE, et al. Replacement-fed infants born to HIV-infected mothers in India have a high early post-partum rate of hospitalization. J Nutr 2003; 133: 3153-7.
63. Sachdeva N, Sehgal S, Arora SK. Frequency of drug-resistant variants of HIV-1 coexistent with wild-type in treatment-naive patients of India. MedGenMed 2005; 7: 68.
64. Shivraj SO, Chattopadhya D, Grover G, Kumar A, Baveja-UK. Role of HCV coinfection towards disease progression and survival in HIV-1 infected childrem a follow-up study of 10 years. J Trop Pediatr 2006; 52: 206-11.
65. Soundararajan L, Karunaianandham R, Jauvin V, et al. Characterization of HIV-1 isolates from antiretroviral drug-naive children in southern India. AIDS Res Hum Retroviruses 2007; 23: 1119-26.
66. Maitra A, Singh B, Banu S, et al. Subtypes of HIV type 1 circulating in India: partial envelope sequences. AIDS Res Hum Retroviruses 1999; 15: 941-4.
67. Kurle SN, Gangakhedkar RR, Sen S, Hayatnagarkar SS, Tripathy SP, Paranjape RS. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C- infected infants in India. AIDS Res Hum Retroviruses 2007; 23: 682-5.
68. Chattopadhya D, Baveja UK, Bose M, Kumar A. Disease progression markers during asymptomatic phase of HIV-1 infected children with unimpaired CD4+ cell values: evaluation of repeat CD4+ cell evaluation vs other immunological parameters. J Trop Pediatr 2002; 48: 340-7.
69. Agnihotri KD, Tripathy SP, Jere AJ, Kale SM, Paranjape RS. Molecular analysis of gp41 sequences of HIV type 1 subtype C from India. J Acquir Immune Defic Syndr 2006; 41: 345-51.
70. World Health Organization. Antiretrovinal therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Recommendations for a public health approach, 2006. Available at: http://www.who.int/hiv/pub/guidelines/WHOpaediatric.pdf (Accessed March 22, 2008).
71. Hatano H, Hunt P, Weidler J, et al. Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen. Clin Infect Dis 2006; 43: 1329-36.
72. Government of India. Ministry of Health and Family Welfare. National Commission on Macroeconomics and Health Reports. Financing and Delivery of Health Care Services in India. 2005. Available at: http://www.who.int/ macrohealth/en/ (Accessed March 22, 2008).
73. Global AIDS Alliance. Children Left Out: Global Community Failing to Scale Up the Prevention and Treatment of Pediatric HIV/AIDS. 2006. Available at: http://www.globalaidsalliance.org (Accessed August 22, 2007).
74. Ministry of Health and Family Welfare, Government of India. National Fact Sheet: India. 2005-2006 National Family Health Survey (NFHS-3); pages 47, 78, 89, 94, 111. Available at: http://www.nfhsindia.org/ factsheet.html (Accessed March 22, 2008).
75. World Health Organization. 2006 Report on the Global AIDS Epidemic. Annex 1: Country Profiles: India. Available at- http://www.who.int/hiv/ mediacentre/2006_GR_ANNlA-L_en.pdf (Accessed March 22, 2008).
76. Centers for Disease Control. HIV/AIDS Surveillance Report: HIV Infection and AIDS in the United States and Dependent Areas, 2005. Available at: http://www.cdc.gov/hiv/topics/surveillance/basic.htm#hivaidsage (Accessed March 22, 2008).
77. UNAIDS, WHO. Report on the global AIDS epidemic, December 2006. Available at: http://www.unaids.org/en/HIV⊣ta/epi2006/ Accessed March 22, 2008.
78. Dandona R, Dandona L, Gutierrez JP, et al. High risk of HIV in non-brothel based female sex workers in India. BMC Public Health 2005; 5: 87.
79. Silverman JG, Decker MR, Gupta J, Maheshwari A, Patel V, Raj A. HIV prevalence and predictors among rescued sex-trafficked women and girls in Mumbai, India. J Acquir Immune Defic Syndr 2006; 43: 588-93.
80. Sarkar K, Bal B, Mukherjee R, Niyogi SK, Saha MK, Bhattacharya SK. Epidemiology of HIV infection among brothel-based sex workers in Kolkata, India. J Health Popal Nutr 2005; 23: 231-5.
81. NACO. National Baseline General Population Behavioural Surveillance Survey, 2001. Available at: http://www.nacoonline.org/publication.htm (Accessed March 22, 2008).
82. Bhore AV, Sastry J, Patke D, et al. Sensitivity and specificity of rapid HIV testing of pregnant women in India. Int J STD AIDS 2003; 14: 37-41.
83. Bharucha KE, Sastry J, Shrotri A, et al. Feasibility of voluntary counselling and testing services for HIV among pregnant women presenting in labour in Pune, India. Int J STD AIDS 2005; 16: 553-5.
84. Regional Office for South-East Asia. World Health Organization. Improving Maternal newborn and child health-India. Available at: http://www.searo.who.int/LinkFiles/ Improving_maternal_newborn_and_child_health_india.pdf (Accessed March 3, 2008).
85. National AIDS Control Organization. Prevention of Parent to Child Transmission. Available at: http://www.nacoonline.org/NACO/ (Accessed March 22, 2008).
86. Registrar General & Census Commissioner, India. Census of India 2001. India at a glance: Sex Ratio. Available at: http://www.censusindia.gov.in/ (Accessed March 22, 2008).
87. Nyandiko WM, Ayaya S, Nabakwe E, et al. Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya. J Acquir Immune Defic Syndr 2006; 43; 418-25.
88. Puthanakit T, Oberdorfer A, Akarathum N, et al. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program. Clin Infect Dis 2005; 41: 100-7.
89. Zhang F, Au MC, Bouey PD, et al. The diagnosis and treatment of HIV-infected children in China: challenges and opportunities. J Acquir Immune Defic Syndr 2007; 44: 429-34.
90. Berk DR, Falkovitz-Halpern MS, Hill DW, et al. Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. JAMA 2005; 293: 2221-31.
91. Doerholt K, Duong T, Tookey P, et al. Outcomes for human immunodeficiency virus-1-infected infants in the United kingdom and Republic of Ireland in the era of effective antiretroviral therapy. Pediatr Infect Dis J 2006; 25: 420-6.
92. Jha P, Kumar R, Vasa P, Dhingra N, Thiruchelvam D, Moineddin R. Low female[corrected]-to-male [corrected] sex ratio of children born in India: national survey of 1.1 million households. Lancet 2006; 367: 211-8.
93. Sharma BR, Gupta N, Relhan N. Misuse of prenatal diagnostic technology for sex-selected abortions and its consequences in India. Public Health 2007; 121: 854-60.
94. Laufer MK, van Oosterhout JJ, Perez MA, et al. Observational cohort study of HIV-infected African children. Pediatr Infect Dis J 2006; 25: 623-7.
95. Vetter KM, Djomand G, Zadi F, et al. Clinical spectrum of human immunodeficiency virus disease in children in a west African city. Project RETRO-CI. Pediatr Infect Dis J 1996; 15: 438-42.
96. Meyers TM, Pettifor JM, Gray GE, Crewe-Brown H, Galpin JS. Pediatric admissions with human immunodeficiency virus infection at a regional hospital in Soweto, South Africa. J Trop Pediatr 2000; 46: 224-30.
97. Spira R, Lepage P, Msellati P, et al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group. Pediatrics 1999; 104: e56.
98. Bobat R, Coovadia H, Moodley D, Coutsoudis A. Mortality in a cohort of children born to HIV-1 infected women from Durban, South Africa. S Afr Med J 1999; 89: 646-8.
99. World Health Organization. WHO HIV and Infant Feeding Technical Consultation: Held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV infections in pregnant women, mothers, and their infants [PDF], Geneva (October 25-27, 2006).
100. Kabue MM, Kekitiinwa A, Maganda A, Risser JM, Chan W, Kline MW. Growth in HIV-infected children receiving antiretroviral therapy at a pediatric infectious diseases clinic in Uganda. AIDS Patient Care STDS 2008; 22: 245-51.